S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)

NCT04141670 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

RyCarma Therapeutics, Inc.

Collaborators